Design and Development of New Anticancer Agents with Selectivity for Tumors and Their Metastases
A special issue of Molecules (ISSN 1420-3049). This special issue belongs to the section "Medicinal Chemistry".
Deadline for manuscript submissions: closed (31 March 2022) | Viewed by 334
Special Issue Editor
Interests: molecular biology of cancer; anticancer drugs; pharmacology; synthesis; drug design
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
The design and development of new anticancer agents with selectivity for tumors and their metastases is a very broad and popular topic in the new approach to medicinal chemistry. The aim of this Special Issue is to provide a wide spectrum of the newest strategies in drug development explored in research teams. First, we want to identify the most popular structures present in many anticancer compounds known as privileged structures. Additionally, we want to collect the most important molecular targets (signaling pathways, proteins involved, receptors, etc.) which are of interest to researchers focused on anticancer therapy.
Dr. Anna Mrozek-Wilczkiewicz
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Molecules is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- Metal complexes
- Privileged structures
- Oxidative stress
- Metastases
- Anticancer targets in the cell
